Biopharmaceutical Excipients Market by Product, Function, Application

Description

List of Tables

[180 Pages Report] The Biopharmaceutical Excipients Market size was estimated at USD 2.08 billion in 2022 and expected to reach USD 2.29 billion in 2023, at a CAGR 10.69% to reach USD 4.70 billion by 2030.

Global Biopharmaceutical Excipients Market

KEY MARKET STATISTICS
Base Year [2022]	USD 2.08 billion
Estimated Year [2023]	USD 2.29 billion
Forecast Year [2030]	USD 4.70 billion
CAGR (%)	10.69%

Biopharmaceutical Excipients Market - IMG1

Biopharmaceutical excipients are substances other than therapeutic molecules that are included in a biopharmaceutical formulation to aid in the production, stability, usability, and delivery of the drug. Biopharmaceutical excipients play a pivotal role in drug formulation. Their applications span diverse categories, such as binders, fillers, diluents, disintegrants, and stabilizers. Rising demand for advanced and functional biopharmaceutical drug formulations and increasing need for large-molecule development are driving the adoption of biopharmaceutical excipients. In addition, rising investment in drug development is boosting the utilization of biopharmaceutical excipients. However, the compatibility issues of biopharmaceutical formulations with active pharmaceutical ingredients pose considerable challenges. Furthermore, the continuous development of biologics and biosimilars leads to an increased need for compatible excipients. Technological advancements in extended-release formulations and the exploration of alternative routes of administration provide significant potential for market expansion.

Regional Insights

In the Americas, the United States stands as a dominant player within the biopharmaceutical excipients market due to a robust pharmaceutical industry, significant investment in R&D, and a steady number of FDA approvals. Canada contributes to regional demand, and both countries exhibit a high interest in novel, multifunctional excipients that enhance drug delivery and stability. European Union (EU) countries possess a well-established pharmaceutical sector with stringent regulatory standards. Consumer need is driven by the production of biosimilars and biologics that demand high-quality ingredients. Ongoing investments by the European Union in research and innovation programs indicate a continued commitment to excipient development, including potential patent applications that aim at improving the performance and safety of biopharmaceuticals. In the APAC region, the focus is on the innovation and development of new excipients and a strong government push for upgrading the pharmaceutical industry. In India, a hub for generic drug production, the excipient demand aligns with cost efficiency and compliance with international standards. Across the Asia Pacific, diverse customer needs steer the demand for specific excipients, which are expected to fuel market growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopharmaceutical Excipients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopharmaceutical Excipients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Ashland Global Holdings Inc., BASF SE, Clariant International Ltd., Colorcon, Inc., Croda International PLC, DFE Pharma GmbH & Co KG, Eastman Chemical Company, Evonik Industries AG, Fuji Chemical Industries Co., Ltd., IMCD N.V., Innophos Holdings, Inc., J. Rettenmaier & Sohne GmbH + Co KG, Meggle Group GmbH, Merck KGaA, Roquette Freres S.A., Sigachi Industries Limited, Spectrum Laboratory Products, Inc., SPI Pharma, Inc., The Dow Chemical Company, The Lubrizol Corporation, VWR International, LLC by Avantor, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Excipients Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Carbohydrates
  - Dextrose
  - Starch
  - Sucrose
- Polyols
  - Mannitol
  - Sorbitol
- Solubilizers & Surfactants/Emulsifiers
  - Esters
  - Triglycerides
- Specialty Excipients
Function
- Binders
- Coatings
- Disintegrants
- Lubricants & glidants
- Pharmaceutical Fillers
- Preservatives
Application
- Advanced Delivery System
- Oral
- Parenteral
- Topical
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biopharmaceutical Excipients Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopharmaceutical Excipients Market?

3. What are the technology trends and regulatory frameworks in the Biopharmaceutical Excipients Market?

4. What is the market share of the leading vendors in the Biopharmaceutical Excipients Market?

5. Which modes and strategic moves are suitable for entering the Biopharmaceutical Excipients Market?

Product Code: MRR-A339DAEFAD8C

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Biopharmaceutical Excipients Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising Demand for Advanced and Functional Biopharmaceutical Drug Formulations
  - 5.1.1.2. Increasing Need for Large-Molecule Development
  - 5.1.1.3. Increasing Development of Biosimilars
  - 5.1.1.4. Increasing Demand for Hormone and Gene Therapy
  - 5.1.1.5. Bulk Vaccine Production Worldwide
- 5.1.2. Restraints
  - 5.1.2.1. High Price of Biopharmaceutical Excipients
- 5.1.3. Opportunities
  - 5.1.3.1. Emerging Trends of Outsourcing for the Production of Biologics
  - 5.1.3.2. Substantial Rise in Need of Functional Excipients
  - 5.1.3.3. Developments in Recombinant DNA Technologies
- 5.1.4. Challenges
  - 5.1.4.1. Manufacturing Complexities and Contamination Issues of Biopharmaceutical Excipients
  - 5.1.4.2. Time Consuming Biopharmaceutical Clinical Trials
5.2. Market Segmentation Analysis
- 5.2.1. Product: Carbohydrates are prominent excipients used in pharmaceutical formulations for formulation stability and patient compliance
- 5.2.2. Function: Increasing utilization of preservatives in biologic formulation for improved stability
- 5.2.3. Application: Growing significance of biopharmaceutical excipients in advanced delivery systems for control drug release
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter's Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Biopharmaceutical Excipients Market, by Product

6.1. Introduction
6.2. Carbohydrates
- 6.3.1. Dextrose
- 6.3.2. Starch
- 6.3.3. Sucrose
6.3. Polyols
- 6.4.1. Mannitol
- 6.4.2. Sorbitol
6.4. Solubilizers & Surfactants/Emulsifiers
- 6.5.1. Esters
- 6.5.2. Triglycerides
6.5. Specialty Excipients

7. Biopharmaceutical Excipients Market, by Function

7.1. Introduction
7.2. Binders
7.3. Coatings
7.4. Disintegrants
7.5. Lubricants & glidants
7.6. Pharmaceutical Fillers
7.7. Preservatives

8. Biopharmaceutical Excipients Market, by Application

8.1. Introduction
8.2. Advanced Delivery System
8.3. Oral
8.4. Parenteral
8.5. Topical

9. Americas Biopharmaceutical Excipients Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Biopharmaceutical Excipients Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Biopharmaceutical Excipients Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. New Product Launch & Enhancement
  - 12.3.1.1. Roquette launches three moisture-protecting ingredients for nutraceuticals
- 12.3.2. Award, Recognition, & Expansion
  - 12.3.2.1. Croda Pharma Breaks Ground on Excipients Manufacturing Facility

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. ABITEC Corporation
- 13.1.2. Actylis
- 13.1.3. Ashland Global Holdings Inc.
- 13.1.4. BASF SE
- 13.1.5. Clariant International Ltd.
- 13.1.6. Colorcon, Inc.
- 13.1.7. Croda International PLC
- 13.1.8. DFE Pharma GmbH & Co KG
- 13.1.9. Eastman Chemical Company
- 13.1.10. Evonik Industries AG
- 13.1.11. Fuji Chemical Industries Co., Ltd.
- 13.1.12. IMCD N.V.
- 13.1.13. Innophos Holdings, Inc.
- 13.1.14. J. Rettenmaier & Sohne GmbH + Co KG
- 13.1.15. Meggle Group GmbH
- 13.1.16. Merck KGaA
- 13.1.17. Roquette Freres S.A.
- 13.1.18. Sigachi Industries Limited
- 13.1.19. Spectrum Laboratory Products, Inc.
- 13.1.20. SPI Pharma, Inc.
- 13.1.21. The Dow Chemical Company
- 13.1.22. The Lubrizol Corporation
- 13.1.23. VWR International, LLC by Avantor
- 13.1.24. Wacker Chemie AG
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing